PAVM
Income statement / Annual
Last year (2024), PAVmed Inc.'s total revenue was $3.00 B,
an increase of 122,045.19% from the previous year.
In 2024, PAVmed Inc.'s net income was $31.97 B.
See PAVmed Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$3.00 B |
$2.45 M |
$377,000.00 |
$500,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$4.84 B
|
$6.42 M
|
$3.61 M
|
$585,000.00
|
$23,000.00
|
$14,226.00
|
$9,790.00
|
$7,110.00
|
$3,793.00
|
$0.00
|
| Gross Profit |
-$1.85 B
|
-$3.97 M
|
-$3.24 M
|
-$85,000.00
|
-$23,000.00
|
-$14,226.00
|
-$9,790.00
|
-$7,110.00
|
-$3,793.00
|
$0.00
|
| Gross Profit Ratio |
-0.62
|
-1.62
|
-8.59
|
-0.17
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$5.93 B
|
$14.28 M
|
$25.55 M
|
$19.85 M
|
$10.96 M
|
$6.63 M
|
$4.25 M
|
$2.62 M
|
$1.72 M
|
$489,327.00
|
| General & Administrative Expenses |
$24.52 B
|
$30.95 M
|
$41.04 M
|
$25.57 M
|
$12.39 M
|
$7.66 M
|
$6.31 M
|
$5.42 M
|
$3.93 M
|
$1.29 M
|
| Selling & Marketing Expenses |
$11.63 B
|
$17.58 M
|
$19.32 M
|
$8.90 M
|
$2.79 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$36.15 B
|
$48.53 M
|
$60.36 M
|
$34.46 M
|
$12.39 M
|
$7.66 M
|
$6.31 M
|
$5.42 M
|
$3.93 M
|
$1.29 M
|
| Other Expenses |
$559.00 M
|
$2.02 M
|
$1.78 M
|
$0.00
|
$0.00
|
-$558,599.00
|
-$903,000.00
|
-$3.12 M
|
$0.00
|
$0.00
|
| Operating Expenses |
$42.64 B
|
$64.83 M
|
$87.69 M
|
$54.31 M
|
$23.35 M
|
$14.30 M
|
$10.56 M
|
$8.03 M
|
$5.65 M
|
$1.78 M
|
| Cost And Expenses |
$47.48 B
|
$71.25 M
|
$91.30 M
|
$54.89 M
|
$23.35 M
|
$14.30 M
|
$10.56 M
|
$8.03 M
|
$5.65 M
|
$1.78 M
|
| Interest Income |
$254.00 M
|
$505,000.00
|
$1.27 M
|
$0.00
|
$53,000.00
|
$33,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
-$45.00 M
|
$589,000.00
|
$1.27 M
|
$0.00
|
$53,000.00
|
$32,667.00
|
$2.39 M
|
$724,684.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$2.93 M
|
$2.55 M
|
$226,000.00
|
$23,000.00
|
$14,226.00
|
$9,790.00
|
$7,110.00
|
$3,793.00
|
$1.78 M
|
| EBITDA |
-$44.49 B |
-$75.74 M |
-$99.41 M |
-$55.90 M |
-$35.81 M |
-$16.67 M |
-$12.07 M |
-$11.15 M |
-$5.65 M |
-$1.78 M |
| EBITDA Ratio |
-14.85
|
-30.89
|
-263.69
|
-108.33
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-14.85
|
-28.06
|
-241.19
|
-108.79
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$72.91 B
|
-$10.47 M
|
-$12.15 M
|
-$1.73 M
|
-$12.54 M
|
-$2.97 M
|
-$7.61 M
|
-$1.49 M
|
$0.00
|
$0.00
|
| Income Before Tax |
$28.43 B
|
-$79.26 M
|
-$103.24 M
|
-$56.13 M
|
-$35.89 M
|
-$17.27 M
|
-$18.17 M
|
-$9.52 M
|
-$5.65 M
|
-$1.78 M
|
| Income Before Tax Ratio |
9.49
|
-32.33
|
-273.84
|
-112.25
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$3.54 B
|
$0.00
|
-$1.94 M
|
-$5.78 M
|
-$1.56 M
|
-$1.34 M
|
-$204,072.00
|
$878,865.00
|
-$1.00
|
-$1.78 M
|
| Net Income |
$31.97 B
|
-$64.18 M
|
-$101.29 M
|
-$50.35 M
|
-$34.33 M
|
-$15.93 M
|
-$17.97 M
|
-$9.52 M
|
-$5.65 M
|
-$1.78 M
|
| Net Income Ratio |
10.67
|
-26.17
|
-268.68
|
-100.69
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
3.3 |
-9.164 |
-15.0316 |
-9.7974 |
-10.9302 |
-8.309 |
-12.6261 |
-11.55 |
-6.6 |
-2.0022 |
| EPS Diluted |
3.3 |
-9.164 |
-15.0316 |
-9.7974 |
-10.9302 |
-8.309 |
-12.6261 |
-11.55 |
-6.6 |
-2.0022 |
| Weighted Average Shares Out |
$9.67 M
|
$7.23 M
|
$5.94 M
|
$5.17 M
|
$3.16 M
|
$2.01 M
|
$1.49 M
|
$899,730.00
|
$864,810.00
|
$887,333.00
|
| Weighted Average Shares Out Diluted |
$9.67 M
|
$7.23 M
|
$5.94 M
|
$5.17 M
|
$3.16 M
|
$2.01 M
|
$1.49 M
|
$899,730.00
|
$864,810.00
|
$887,333.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
